Central Line-Associated Bloodstream Infection QI Project

Part of paid clinical trials in New York, New York.

Sponsor
NYU Langone Health
Study ID
NCT07746674
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Central Line-associated Bloodstream Infection (CLABSI)

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

This study evaluates a daily electronic health record (EHR) alert designed to reduce unnecessary central venous catheter (CVC) use among hospitalized adults. The alert identifies patients with an active CVC and no documented indication, prompting the first-contact provider to document line necessity. The study compares alert and a secure chat intervention to usual care, with the goal of reducing unnecessary line days and related CLABSI risk.

Key Dates

First listed
Aug 5, 2026
Start date
Sep 30, 2026
Status verified
Jul 2026
Primary completion
Sep 30, 2026
Completion
Mar 31, 2027

Study Design

Enrollment
30 participants (estimated)

Arms

  • Arm: Usual Care
    Adult inpatients meeting eligibility criteria.
  • Arm: Secure Chat + Alert Cohort
    Adult inpatients meeting eligibility criteria whose provider receives a daily EHR OPA alert and additional secure chat communication.

Primary Outcome Measure

Total number of central line days without a documented indication [ Time Frame: Up to Month 3 ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
NYU Langone HealthNew YorkNew York10016-

Find similar trials in New York, NY

By research site
NYU Langone Health· New York, NY